Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

Dept: School of Pharmacy

You searched for subject:(Drug delivery). Showing records 1 – 19 of 19 total matches.

Search Limiters

Last 2 Years | English Only

No search limiters apply to these results.

▼ Search Limiters

1. Marzijarani, Tayebeh Anajafi. Targeted Drug Delivery in Pancreatic Cancer.

Degree: PhD, School of Pharmacy, 2017, North Dakota State University

Tayebeh Anajafi Marzijarani, 2017 North Dakota State University Three Minute Thesis (3MT) competition champion, talks about her research on targeted drug delivery for pancreatic cancer.

Subjects/Keywords: Drug delivery systems.; Pancreatic cancer.

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Marzijarani, T. A. (2017). Targeted Drug Delivery in Pancreatic Cancer. (Doctoral Dissertation). North Dakota State University. Retrieved from http://hdl.handle.net/10365/27554

Chicago Manual of Style (16th Edition):

Marzijarani, Tayebeh Anajafi. “Targeted Drug Delivery in Pancreatic Cancer.” 2017. Doctoral Dissertation, North Dakota State University. Accessed March 26, 2019. http://hdl.handle.net/10365/27554.

MLA Handbook (7th Edition):

Marzijarani, Tayebeh Anajafi. “Targeted Drug Delivery in Pancreatic Cancer.” 2017. Web. 26 Mar 2019.

Vancouver:

Marzijarani TA. Targeted Drug Delivery in Pancreatic Cancer. [Internet] [Doctoral dissertation]. North Dakota State University; 2017. [cited 2019 Mar 26]. Available from: http://hdl.handle.net/10365/27554.

Council of Science Editors:

Marzijarani TA. Targeted Drug Delivery in Pancreatic Cancer. [Doctoral Dissertation]. North Dakota State University; 2017. Available from: http://hdl.handle.net/10365/27554


Northeastern University

2. Panwar, Rajiv. Reduction of the cardiotoxicity of doxorubicin: demonstration by in vivo imaging with bispecific antibody/radiolabeled negatively charged polymers.

Degree: PhD, School of Pharmacy, 2012, Northeastern University

 ECG and serum CK-MB (creatinine kinase) or cardiac troponin analyses are the routine tests for the diagnosis of myocardial necrosis. Borderline CK-MB elevations and uninterpretable… (more)

Subjects/Keywords: Pharmaceutics and Drug delivery systems; Pharmaceutics and Drug Design; Pharmacy and Pharmaceutical Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Panwar, R. (2012). Reduction of the cardiotoxicity of doxorubicin: demonstration by in vivo imaging with bispecific antibody/radiolabeled negatively charged polymers. (Doctoral Dissertation). Northeastern University. Retrieved from http://hdl.handle.net/2047/d20002959

Chicago Manual of Style (16th Edition):

Panwar, Rajiv. “Reduction of the cardiotoxicity of doxorubicin: demonstration by in vivo imaging with bispecific antibody/radiolabeled negatively charged polymers.” 2012. Doctoral Dissertation, Northeastern University. Accessed March 26, 2019. http://hdl.handle.net/2047/d20002959.

MLA Handbook (7th Edition):

Panwar, Rajiv. “Reduction of the cardiotoxicity of doxorubicin: demonstration by in vivo imaging with bispecific antibody/radiolabeled negatively charged polymers.” 2012. Web. 26 Mar 2019.

Vancouver:

Panwar R. Reduction of the cardiotoxicity of doxorubicin: demonstration by in vivo imaging with bispecific antibody/radiolabeled negatively charged polymers. [Internet] [Doctoral dissertation]. Northeastern University; 2012. [cited 2019 Mar 26]. Available from: http://hdl.handle.net/2047/d20002959.

Council of Science Editors:

Panwar R. Reduction of the cardiotoxicity of doxorubicin: demonstration by in vivo imaging with bispecific antibody/radiolabeled negatively charged polymers. [Doctoral Dissertation]. Northeastern University; 2012. Available from: http://hdl.handle.net/2047/d20002959


Northeastern University

3. Jain, Shardool. Macrophage targeted tuftsin-modified alginate nanoparticles as non-viral delivery system for anti-inflammatory gene therapy in the treatment of rheumatoid arthritis.

Degree: PhD, School of Pharmacy, 2014, Northeastern University

 The goal of this project is to develop and characterize a macrophage targeted alginate polymer based gene delivery system for the treatment of rheumatoid arthritis… (more)

Subjects/Keywords: targeted delivery; Polymeric drug delivery systems; Nanoparticles; Therapeutic use; Gene therapy; Rheumatoid arthritis; Treatment; Rheumatoid arthritis; Animal models; Alginates; Macrophages

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Jain, S. (2014). Macrophage targeted tuftsin-modified alginate nanoparticles as non-viral delivery system for anti-inflammatory gene therapy in the treatment of rheumatoid arthritis. (Doctoral Dissertation). Northeastern University. Retrieved from http://hdl.handle.net/2047/D20204485

Chicago Manual of Style (16th Edition):

Jain, Shardool. “Macrophage targeted tuftsin-modified alginate nanoparticles as non-viral delivery system for anti-inflammatory gene therapy in the treatment of rheumatoid arthritis.” 2014. Doctoral Dissertation, Northeastern University. Accessed March 26, 2019. http://hdl.handle.net/2047/D20204485.

MLA Handbook (7th Edition):

Jain, Shardool. “Macrophage targeted tuftsin-modified alginate nanoparticles as non-viral delivery system for anti-inflammatory gene therapy in the treatment of rheumatoid arthritis.” 2014. Web. 26 Mar 2019.

Vancouver:

Jain S. Macrophage targeted tuftsin-modified alginate nanoparticles as non-viral delivery system for anti-inflammatory gene therapy in the treatment of rheumatoid arthritis. [Internet] [Doctoral dissertation]. Northeastern University; 2014. [cited 2019 Mar 26]. Available from: http://hdl.handle.net/2047/D20204485.

Council of Science Editors:

Jain S. Macrophage targeted tuftsin-modified alginate nanoparticles as non-viral delivery system for anti-inflammatory gene therapy in the treatment of rheumatoid arthritis. [Doctoral Dissertation]. Northeastern University; 2014. Available from: http://hdl.handle.net/2047/D20204485


Northeastern University

4. Dodwadkar, Namita. Surface modification of nanocarriers for intra-cellular and sub-cellular targeting and delivery.

Degree: PhD, School of Pharmacy, 2013, Northeastern University

 Subcellular targeting is important for efficient delivery of particulate drugs to organelles of interest for both maximum therapeutic effects and for minimum side-effects associated with… (more)

Subjects/Keywords: anti-cancer; dendrimer; drug delivery; liposome; mitochondria; targeting; Pharmaceutics and Drug Design; Pharmacy and Pharmaceutical Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Dodwadkar, N. (2013). Surface modification of nanocarriers for intra-cellular and sub-cellular targeting and delivery. (Doctoral Dissertation). Northeastern University. Retrieved from http://hdl.handle.net/2047/d20003240

Chicago Manual of Style (16th Edition):

Dodwadkar, Namita. “Surface modification of nanocarriers for intra-cellular and sub-cellular targeting and delivery.” 2013. Doctoral Dissertation, Northeastern University. Accessed March 26, 2019. http://hdl.handle.net/2047/d20003240.

MLA Handbook (7th Edition):

Dodwadkar, Namita. “Surface modification of nanocarriers for intra-cellular and sub-cellular targeting and delivery.” 2013. Web. 26 Mar 2019.

Vancouver:

Dodwadkar N. Surface modification of nanocarriers for intra-cellular and sub-cellular targeting and delivery. [Internet] [Doctoral dissertation]. Northeastern University; 2013. [cited 2019 Mar 26]. Available from: http://hdl.handle.net/2047/d20003240.

Council of Science Editors:

Dodwadkar N. Surface modification of nanocarriers for intra-cellular and sub-cellular targeting and delivery. [Doctoral Dissertation]. Northeastern University; 2013. Available from: http://hdl.handle.net/2047/d20003240


Northeastern University

5. Yadav, Sunita. Intranasal delivery for peptide and siRNA to the brain using lipid-based nanocarriers for the treatment of neuroinflammation.

Degree: PhD, School of Pharmacy, 2015, Northeastern University

 Neurodegenerative diseases are the most prevalent brain diseases affecting more than 5.5 million people worldwide. If left unconstrained, 30 years from now, more than 12… (more)

Subjects/Keywords: neurodegenerative diseases; intranasal drug delivery; Intranasal medication; Small interfering RNA; Therapeutic use; Peptides; Therapeutic use; Nervous system; Degeneration; Animal models; Nanomedicine; Drug delivery systems; Blood-brain barrier

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Yadav, S. (2015). Intranasal delivery for peptide and siRNA to the brain using lipid-based nanocarriers for the treatment of neuroinflammation. (Doctoral Dissertation). Northeastern University. Retrieved from http://hdl.handle.net/2047/D20198907

Chicago Manual of Style (16th Edition):

Yadav, Sunita. “Intranasal delivery for peptide and siRNA to the brain using lipid-based nanocarriers for the treatment of neuroinflammation.” 2015. Doctoral Dissertation, Northeastern University. Accessed March 26, 2019. http://hdl.handle.net/2047/D20198907.

MLA Handbook (7th Edition):

Yadav, Sunita. “Intranasal delivery for peptide and siRNA to the brain using lipid-based nanocarriers for the treatment of neuroinflammation.” 2015. Web. 26 Mar 2019.

Vancouver:

Yadav S. Intranasal delivery for peptide and siRNA to the brain using lipid-based nanocarriers for the treatment of neuroinflammation. [Internet] [Doctoral dissertation]. Northeastern University; 2015. [cited 2019 Mar 26]. Available from: http://hdl.handle.net/2047/D20198907.

Council of Science Editors:

Yadav S. Intranasal delivery for peptide and siRNA to the brain using lipid-based nanocarriers for the treatment of neuroinflammation. [Doctoral Dissertation]. Northeastern University; 2015. Available from: http://hdl.handle.net/2047/D20198907


Northeastern University

6. Riehle, Robert Donald. Combination anticancer nanopreparations of novel proapoptotic drug, TRAIL and siRNA.

Degree: PhD, School of Pharmacy, 2013, Northeastern University

 Development of drugs for the treatment of cancer is a challenging endeavor often hindered by the solubility and distribution of the drug in the body.… (more)

Subjects/Keywords: Combination Therapy; Drug Delivery; Micelles; Nanomedicine; siRNA; Nanoscience and Nanotechnology; Pharmacy and Pharmaceutical Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Riehle, R. D. (2013). Combination anticancer nanopreparations of novel proapoptotic drug, TRAIL and siRNA. (Doctoral Dissertation). Northeastern University. Retrieved from http://hdl.handle.net/2047/d20003287

Chicago Manual of Style (16th Edition):

Riehle, Robert Donald. “Combination anticancer nanopreparations of novel proapoptotic drug, TRAIL and siRNA.” 2013. Doctoral Dissertation, Northeastern University. Accessed March 26, 2019. http://hdl.handle.net/2047/d20003287.

MLA Handbook (7th Edition):

Riehle, Robert Donald. “Combination anticancer nanopreparations of novel proapoptotic drug, TRAIL and siRNA.” 2013. Web. 26 Mar 2019.

Vancouver:

Riehle RD. Combination anticancer nanopreparations of novel proapoptotic drug, TRAIL and siRNA. [Internet] [Doctoral dissertation]. Northeastern University; 2013. [cited 2019 Mar 26]. Available from: http://hdl.handle.net/2047/d20003287.

Council of Science Editors:

Riehle RD. Combination anticancer nanopreparations of novel proapoptotic drug, TRAIL and siRNA. [Doctoral Dissertation]. Northeastern University; 2013. Available from: http://hdl.handle.net/2047/d20003287


Northeastern University

7. Sawant, Rishikesh Manohar. Polyethylene glycol (PEG) as a key component of long-circulating delivery systems for therapy and imaging.

Degree: PhD, School of Pharmacy, 2008, Northeastern University

 The undesired side-effects of many therapies and diagnostics result from their accumulation in the non-target tissues. There is a clear need to design pharmaceutical delivery(more)

Subjects/Keywords: Health science; Drug delivery systems; Nanotechnology; Polymeric drug delivery systems; Drug delivery systems; Pharmacy and Pharmaceutical Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Sawant, R. M. (2008). Polyethylene glycol (PEG) as a key component of long-circulating delivery systems for therapy and imaging. (Doctoral Dissertation). Northeastern University. Retrieved from http://hdl.handle.net/2047/d1001701x

Chicago Manual of Style (16th Edition):

Sawant, Rishikesh Manohar. “Polyethylene glycol (PEG) as a key component of long-circulating delivery systems for therapy and imaging.” 2008. Doctoral Dissertation, Northeastern University. Accessed March 26, 2019. http://hdl.handle.net/2047/d1001701x.

MLA Handbook (7th Edition):

Sawant, Rishikesh Manohar. “Polyethylene glycol (PEG) as a key component of long-circulating delivery systems for therapy and imaging.” 2008. Web. 26 Mar 2019.

Vancouver:

Sawant RM. Polyethylene glycol (PEG) as a key component of long-circulating delivery systems for therapy and imaging. [Internet] [Doctoral dissertation]. Northeastern University; 2008. [cited 2019 Mar 26]. Available from: http://hdl.handle.net/2047/d1001701x.

Council of Science Editors:

Sawant RM. Polyethylene glycol (PEG) as a key component of long-circulating delivery systems for therapy and imaging. [Doctoral Dissertation]. Northeastern University; 2008. Available from: http://hdl.handle.net/2047/d1001701x


Northeastern University

8. Harmon, Brendan Trevor. Intranasal delivery of pGDNF nanoparticles for Parkinson's Disease.

Degree: PhD, School of Pharmacy, 2013, Northeastern University

 Parkinson's disease (PD) is a progressive neurodegenerative disorder that primarily affects the dopaminergic A9 nigrostriatal tract. For dopamine neurons specifically, glial cell-derived neurotrophic factor (GDNF)… (more)

Subjects/Keywords: 6-OHDA; Brain delivery; GDNF; Gene therapy; Intranasal; Nanoparticle; Nanomedicine; Neurosciences; Pharmaceutics and Drug Design; Pharmacy and Pharmaceutical Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Harmon, B. T. (2013). Intranasal delivery of pGDNF nanoparticles for Parkinson's Disease. (Doctoral Dissertation). Northeastern University. Retrieved from http://hdl.handle.net/2047/d20003327

Chicago Manual of Style (16th Edition):

Harmon, Brendan Trevor. “Intranasal delivery of pGDNF nanoparticles for Parkinson's Disease.” 2013. Doctoral Dissertation, Northeastern University. Accessed March 26, 2019. http://hdl.handle.net/2047/d20003327.

MLA Handbook (7th Edition):

Harmon, Brendan Trevor. “Intranasal delivery of pGDNF nanoparticles for Parkinson's Disease.” 2013. Web. 26 Mar 2019.

Vancouver:

Harmon BT. Intranasal delivery of pGDNF nanoparticles for Parkinson's Disease. [Internet] [Doctoral dissertation]. Northeastern University; 2013. [cited 2019 Mar 26]. Available from: http://hdl.handle.net/2047/d20003327.

Council of Science Editors:

Harmon BT. Intranasal delivery of pGDNF nanoparticles for Parkinson's Disease. [Doctoral Dissertation]. Northeastern University; 2013. Available from: http://hdl.handle.net/2047/d20003327


Northeastern University

9. Deshpande, Dipti. Multimodal omega-3 fatty acid oil-containing nanoemulsion-based therapeutic strategy for the treatment of endothelial dysfunction in coronary artery disease.

Degree: PhD, School of Pharmacy, 2014, Northeastern University

 Coronary artery disease has been identified as an important predisposing factor in the development of cardiovascular disorders like myocardial infarction. For years, different hypotheses have… (more)

Subjects/Keywords: lesion; nanoemulsion; vascular; Nanoparticles; Drug delivery systems; Vascular endothelium; Estradiol; Therapeutic use; Arteriosclerosis; Coronary heart disease; Pathophysiology; Nitric oxide

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Deshpande, D. (2014). Multimodal omega-3 fatty acid oil-containing nanoemulsion-based therapeutic strategy for the treatment of endothelial dysfunction in coronary artery disease. (Doctoral Dissertation). Northeastern University. Retrieved from http://hdl.handle.net/2047/D20196651

Chicago Manual of Style (16th Edition):

Deshpande, Dipti. “Multimodal omega-3 fatty acid oil-containing nanoemulsion-based therapeutic strategy for the treatment of endothelial dysfunction in coronary artery disease.” 2014. Doctoral Dissertation, Northeastern University. Accessed March 26, 2019. http://hdl.handle.net/2047/D20196651.

MLA Handbook (7th Edition):

Deshpande, Dipti. “Multimodal omega-3 fatty acid oil-containing nanoemulsion-based therapeutic strategy for the treatment of endothelial dysfunction in coronary artery disease.” 2014. Web. 26 Mar 2019.

Vancouver:

Deshpande D. Multimodal omega-3 fatty acid oil-containing nanoemulsion-based therapeutic strategy for the treatment of endothelial dysfunction in coronary artery disease. [Internet] [Doctoral dissertation]. Northeastern University; 2014. [cited 2019 Mar 26]. Available from: http://hdl.handle.net/2047/D20196651.

Council of Science Editors:

Deshpande D. Multimodal omega-3 fatty acid oil-containing nanoemulsion-based therapeutic strategy for the treatment of endothelial dysfunction in coronary artery disease. [Doctoral Dissertation]. Northeastern University; 2014. Available from: http://hdl.handle.net/2047/D20196651


Northeastern University

10. Nagelli, Srikar Goud. Development of transferrin targeted NCL-240 micelles and their evaluation using in-vitro 3D cancer cell culture (spheroid) models.

Degree: MS, School of Pharmacy, 2014, Northeastern University

 The main objective of this project was to develop targeted micellar delivery systems of a novel cytotoxic drug (NCL-240; a second generation DM-PIT-1 analog) and… (more)

Subjects/Keywords: cancer; NCL-240; PI3K pathway; spheroids; transferrin targeting; Drug delivery systems; Nanoparticles; Transferrin; Micelles; Cancer cells; Growth; Phosphoinositides

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Nagelli, S. G. (2014). Development of transferrin targeted NCL-240 micelles and their evaluation using in-vitro 3D cancer cell culture (spheroid) models. (Masters Thesis). Northeastern University. Retrieved from http://hdl.handle.net/2047/D20197620

Chicago Manual of Style (16th Edition):

Nagelli, Srikar Goud. “Development of transferrin targeted NCL-240 micelles and their evaluation using in-vitro 3D cancer cell culture (spheroid) models.” 2014. Masters Thesis, Northeastern University. Accessed March 26, 2019. http://hdl.handle.net/2047/D20197620.

MLA Handbook (7th Edition):

Nagelli, Srikar Goud. “Development of transferrin targeted NCL-240 micelles and their evaluation using in-vitro 3D cancer cell culture (spheroid) models.” 2014. Web. 26 Mar 2019.

Vancouver:

Nagelli SG. Development of transferrin targeted NCL-240 micelles and their evaluation using in-vitro 3D cancer cell culture (spheroid) models. [Internet] [Masters thesis]. Northeastern University; 2014. [cited 2019 Mar 26]. Available from: http://hdl.handle.net/2047/D20197620.

Council of Science Editors:

Nagelli SG. Development of transferrin targeted NCL-240 micelles and their evaluation using in-vitro 3D cancer cell culture (spheroid) models. [Masters Thesis]. Northeastern University; 2014. Available from: http://hdl.handle.net/2047/D20197620


Northeastern University

11. Raikar, Ankita. HIF-1α activation in 3D tumor spheroids and evaluation of 2-methoxyestradiol therapy using targeted nanoparticle formulations; HIF-1 alpha activation in 3D tumor spheroids and evaluation of 2-methoxyestradiol therapy using targeted nanoparticle formulations.

Degree: School of Pharmacy, 2014, Northeastern University

 Despite significant advances in new drug discoveries and treatment combinations, the mortality rate due to cancer has not changed significantly over the last fifty years… (more)

Subjects/Keywords: 2-methoxyestradiol; HIF-1; ovarian cancer; SKOV-3; spheroids; Polymeric drug delivery systems; Neovascularization inhibitors; Nanoparticles; Anoxemia; Ovaries; Cancer; Treatment; Drug resistance in cancer cells; Transcription factors

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Raikar, A. (2014). HIF-1α activation in 3D tumor spheroids and evaluation of 2-methoxyestradiol therapy using targeted nanoparticle formulations; HIF-1 alpha activation in 3D tumor spheroids and evaluation of 2-methoxyestradiol therapy using targeted nanoparticle formulations. (Masters Thesis). Northeastern University. Retrieved from http://hdl.handle.net/2047/D20197979

Chicago Manual of Style (16th Edition):

Raikar, Ankita. “HIF-1α activation in 3D tumor spheroids and evaluation of 2-methoxyestradiol therapy using targeted nanoparticle formulations; HIF-1 alpha activation in 3D tumor spheroids and evaluation of 2-methoxyestradiol therapy using targeted nanoparticle formulations.” 2014. Masters Thesis, Northeastern University. Accessed March 26, 2019. http://hdl.handle.net/2047/D20197979.

MLA Handbook (7th Edition):

Raikar, Ankita. “HIF-1α activation in 3D tumor spheroids and evaluation of 2-methoxyestradiol therapy using targeted nanoparticle formulations; HIF-1 alpha activation in 3D tumor spheroids and evaluation of 2-methoxyestradiol therapy using targeted nanoparticle formulations.” 2014. Web. 26 Mar 2019.

Vancouver:

Raikar A. HIF-1α activation in 3D tumor spheroids and evaluation of 2-methoxyestradiol therapy using targeted nanoparticle formulations; HIF-1 alpha activation in 3D tumor spheroids and evaluation of 2-methoxyestradiol therapy using targeted nanoparticle formulations. [Internet] [Masters thesis]. Northeastern University; 2014. [cited 2019 Mar 26]. Available from: http://hdl.handle.net/2047/D20197979.

Council of Science Editors:

Raikar A. HIF-1α activation in 3D tumor spheroids and evaluation of 2-methoxyestradiol therapy using targeted nanoparticle formulations; HIF-1 alpha activation in 3D tumor spheroids and evaluation of 2-methoxyestradiol therapy using targeted nanoparticle formulations. [Masters Thesis]. Northeastern University; 2014. Available from: http://hdl.handle.net/2047/D20197979


Northeastern University

12. Apte, Anjali Vasant. Multifunctional nanocarriers for enhanced tumor delivery.

Degree: PhD, School of Pharmacy, 2012, Northeastern University

 A tumor is an abnormally growing mass of cells. Ordinary chemotherapeutic agents used to prevent tumor growth produce more side effects and less than desired… (more)

Subjects/Keywords: cell-penetrating peptide; liposomes and micelles; monoclonal antibody; multifunctional nanocarriers; pH-sensitive polymer; tumor drug delivery; Medicinal and Pharmaceutical Chemistry; Pharmaceutics and Drug Design; Pharmacy and Pharmaceutical Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Apte, A. V. (2012). Multifunctional nanocarriers for enhanced tumor delivery. (Doctoral Dissertation). Northeastern University. Retrieved from http://hdl.handle.net/2047/d20002948

Chicago Manual of Style (16th Edition):

Apte, Anjali Vasant. “Multifunctional nanocarriers for enhanced tumor delivery.” 2012. Doctoral Dissertation, Northeastern University. Accessed March 26, 2019. http://hdl.handle.net/2047/d20002948.

MLA Handbook (7th Edition):

Apte, Anjali Vasant. “Multifunctional nanocarriers for enhanced tumor delivery.” 2012. Web. 26 Mar 2019.

Vancouver:

Apte AV. Multifunctional nanocarriers for enhanced tumor delivery. [Internet] [Doctoral dissertation]. Northeastern University; 2012. [cited 2019 Mar 26]. Available from: http://hdl.handle.net/2047/d20002948.

Council of Science Editors:

Apte AV. Multifunctional nanocarriers for enhanced tumor delivery. [Doctoral Dissertation]. Northeastern University; 2012. Available from: http://hdl.handle.net/2047/d20002948


University of Queensland

13. Pathak, Meenakshi. Controlled delivery of antibacterials using polycaprolactone matrices for the intravaginal treatment of sexually transmitted infections.

Degree: School of Pharmacy, 2016, University of Queensland

Subjects/Keywords: Vaginal drug delivery; sexually transmitted infections; polycaprolactone; drug delivery systems; intravaginal rings; 1115 Pharmacology and Pharmaceutical Sciences; 111504 Pharmaceutical Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Pathak, M. (2016). Controlled delivery of antibacterials using polycaprolactone matrices for the intravaginal treatment of sexually transmitted infections. (Thesis). University of Queensland. Retrieved from http://espace.library.uq.edu.au/view/UQ:393207

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Pathak, Meenakshi. “Controlled delivery of antibacterials using polycaprolactone matrices for the intravaginal treatment of sexually transmitted infections.” 2016. Thesis, University of Queensland. Accessed March 26, 2019. http://espace.library.uq.edu.au/view/UQ:393207.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Pathak, Meenakshi. “Controlled delivery of antibacterials using polycaprolactone matrices for the intravaginal treatment of sexually transmitted infections.” 2016. Web. 26 Mar 2019.

Vancouver:

Pathak M. Controlled delivery of antibacterials using polycaprolactone matrices for the intravaginal treatment of sexually transmitted infections. [Internet] [Thesis]. University of Queensland; 2016. [cited 2019 Mar 26]. Available from: http://espace.library.uq.edu.au/view/UQ:393207.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Pathak M. Controlled delivery of antibacterials using polycaprolactone matrices for the intravaginal treatment of sexually transmitted infections. [Thesis]. University of Queensland; 2016. Available from: http://espace.library.uq.edu.au/view/UQ:393207

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Northeastern University

14. Deshpande, Madhura Sanjay. Palmitoyl ascorbate-modified liposomes for the treatment of renal cell carcinoma.

Degree: PhD, School of Pharmacy, 2014, Northeastern University

 Cancer is one of the leading causes of death worldwide. Very limited treatment options exist at present. Nanotechnology has played a major role in cancer… (more)

Subjects/Keywords: palmitoyl ascorbate; Liposomes; Therapeutic use; Drug delivery systems; Protein kinases; Inhibitors; Therapeutic use; Renal cell carcinoma; Treatment; Vitamin C; Therapeutic use; Active oxygen

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Deshpande, M. S. (2014). Palmitoyl ascorbate-modified liposomes for the treatment of renal cell carcinoma. (Doctoral Dissertation). Northeastern University. Retrieved from http://hdl.handle.net/2047/D20196652

Chicago Manual of Style (16th Edition):

Deshpande, Madhura Sanjay. “Palmitoyl ascorbate-modified liposomes for the treatment of renal cell carcinoma.” 2014. Doctoral Dissertation, Northeastern University. Accessed March 26, 2019. http://hdl.handle.net/2047/D20196652.

MLA Handbook (7th Edition):

Deshpande, Madhura Sanjay. “Palmitoyl ascorbate-modified liposomes for the treatment of renal cell carcinoma.” 2014. Web. 26 Mar 2019.

Vancouver:

Deshpande MS. Palmitoyl ascorbate-modified liposomes for the treatment of renal cell carcinoma. [Internet] [Doctoral dissertation]. Northeastern University; 2014. [cited 2019 Mar 26]. Available from: http://hdl.handle.net/2047/D20196652.

Council of Science Editors:

Deshpande MS. Palmitoyl ascorbate-modified liposomes for the treatment of renal cell carcinoma. [Doctoral Dissertation]. Northeastern University; 2014. Available from: http://hdl.handle.net/2047/D20196652


Northeastern University

15. Essex, Sean. Novel phospholipid-modified-polyethylenimine (PLPEI)-based-nanocarriers for siRNA delivery.

Degree: PhD, School of Pharmacy, 2013, Northeastern University

 This project was designed with a clear aim of developing effective, novel, non-viral siRNA nanocarriers for further application in the treatment of Cancer. Micelle-like nanoparticles… (more)

Subjects/Keywords: lipid; nanocarrier; PEI; polymer; siRNA; Nanoparticles; Therapeutic use; Drug delivery systems; Small interfering RNA; Therapeutic use; Polyethylene; Therapeutic use; Polymers; Therapeutic use; Micelles; Therapeutic use; Breast; Cancer; Treatment

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Essex, S. (2013). Novel phospholipid-modified-polyethylenimine (PLPEI)-based-nanocarriers for siRNA delivery. (Doctoral Dissertation). Northeastern University. Retrieved from http://hdl.handle.net/2047/D20196782

Chicago Manual of Style (16th Edition):

Essex, Sean. “Novel phospholipid-modified-polyethylenimine (PLPEI)-based-nanocarriers for siRNA delivery.” 2013. Doctoral Dissertation, Northeastern University. Accessed March 26, 2019. http://hdl.handle.net/2047/D20196782.

MLA Handbook (7th Edition):

Essex, Sean. “Novel phospholipid-modified-polyethylenimine (PLPEI)-based-nanocarriers for siRNA delivery.” 2013. Web. 26 Mar 2019.

Vancouver:

Essex S. Novel phospholipid-modified-polyethylenimine (PLPEI)-based-nanocarriers for siRNA delivery. [Internet] [Doctoral dissertation]. Northeastern University; 2013. [cited 2019 Mar 26]. Available from: http://hdl.handle.net/2047/D20196782.

Council of Science Editors:

Essex S. Novel phospholipid-modified-polyethylenimine (PLPEI)-based-nanocarriers for siRNA delivery. [Doctoral Dissertation]. Northeastern University; 2013. Available from: http://hdl.handle.net/2047/D20196782


Northeastern University

16. Xu, Jing. Multimodal therapeutic strategy for pancreatic cancer: EGFR-targeted gelatin-based nanoparticles for combination wild-type p53 gene and cytotoxic drug delivery.

Degree: PhD, School of Pharmacy, 2013, Northeastern University

 Pancreatic adenocarcinoma is the fourth lethal cancer in the United States. Many therapeutic strategies such as the chemotherapy and gene therapy have been applied as… (more)

Subjects/Keywords: Drug Delivery; epidermal growth factor receptor (EGFR) targeting; Gene Therapy; Pancreatic Cancer; Thiolated type B gelatin nanoparticles; wild type p53; Medicinal Chemistry and Pharmaceutics; Pharmacology, Toxicology and Environmental Health

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Xu, J. (2013). Multimodal therapeutic strategy for pancreatic cancer: EGFR-targeted gelatin-based nanoparticles for combination wild-type p53 gene and cytotoxic drug delivery. (Doctoral Dissertation). Northeastern University. Retrieved from http://hdl.handle.net/2047/d20003307

Chicago Manual of Style (16th Edition):

Xu, Jing. “Multimodal therapeutic strategy for pancreatic cancer: EGFR-targeted gelatin-based nanoparticles for combination wild-type p53 gene and cytotoxic drug delivery.” 2013. Doctoral Dissertation, Northeastern University. Accessed March 26, 2019. http://hdl.handle.net/2047/d20003307.

MLA Handbook (7th Edition):

Xu, Jing. “Multimodal therapeutic strategy for pancreatic cancer: EGFR-targeted gelatin-based nanoparticles for combination wild-type p53 gene and cytotoxic drug delivery.” 2013. Web. 26 Mar 2019.

Vancouver:

Xu J. Multimodal therapeutic strategy for pancreatic cancer: EGFR-targeted gelatin-based nanoparticles for combination wild-type p53 gene and cytotoxic drug delivery. [Internet] [Doctoral dissertation]. Northeastern University; 2013. [cited 2019 Mar 26]. Available from: http://hdl.handle.net/2047/d20003307.

Council of Science Editors:

Xu J. Multimodal therapeutic strategy for pancreatic cancer: EGFR-targeted gelatin-based nanoparticles for combination wild-type p53 gene and cytotoxic drug delivery. [Doctoral Dissertation]. Northeastern University; 2013. Available from: http://hdl.handle.net/2047/d20003307


Northeastern University

17. Vlerken, Lilian Emilia van. Modulation of multidrug resistance in cancer using polymer blend nanoparticles.

Degree: PhD, School of Pharmacy, 2008, Northeastern University

 The development of multidrug resistance (MDR) to a wide variety of chemotherapeutic agents is one of the most challenging aspects of cancer therapy, and is… (more)

Subjects/Keywords: Health Sciences; Nanotechnology; Cancer; Drug resistance in cancer cells; Multidrug resistance; Drug delivery systems; Pharmacy and Pharmaceutical Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Vlerken, L. E. v. (2008). Modulation of multidrug resistance in cancer using polymer blend nanoparticles. (Doctoral Dissertation). Northeastern University. Retrieved from http://hdl.handle.net/2047/d10017355

Chicago Manual of Style (16th Edition):

Vlerken, Lilian Emilia van. “Modulation of multidrug resistance in cancer using polymer blend nanoparticles.” 2008. Doctoral Dissertation, Northeastern University. Accessed March 26, 2019. http://hdl.handle.net/2047/d10017355.

MLA Handbook (7th Edition):

Vlerken, Lilian Emilia van. “Modulation of multidrug resistance in cancer using polymer blend nanoparticles.” 2008. Web. 26 Mar 2019.

Vancouver:

Vlerken LEv. Modulation of multidrug resistance in cancer using polymer blend nanoparticles. [Internet] [Doctoral dissertation]. Northeastern University; 2008. [cited 2019 Mar 26]. Available from: http://hdl.handle.net/2047/d10017355.

Council of Science Editors:

Vlerken LEv. Modulation of multidrug resistance in cancer using polymer blend nanoparticles. [Doctoral Dissertation]. Northeastern University; 2008. Available from: http://hdl.handle.net/2047/d10017355


University of Queensland

18. Manrique Torres, Yady Juliana. Understanding the mechanism of drug delivery from thickened fluids to aid swallowing of medications.

Degree: School of Pharmacy, 2015, University of Queensland

Subjects/Keywords: Drug Delivery; Dysphagia; Dosage form modification; Drug diffusion; Thickened Fluids; Rheology; 111504 Pharmaceutical Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Manrique Torres, Y. J. (2015). Understanding the mechanism of drug delivery from thickened fluids to aid swallowing of medications. (Thesis). University of Queensland. Retrieved from http://espace.library.uq.edu.au/view/UQ:372163

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Manrique Torres, Yady Juliana. “Understanding the mechanism of drug delivery from thickened fluids to aid swallowing of medications.” 2015. Thesis, University of Queensland. Accessed March 26, 2019. http://espace.library.uq.edu.au/view/UQ:372163.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Manrique Torres, Yady Juliana. “Understanding the mechanism of drug delivery from thickened fluids to aid swallowing of medications.” 2015. Web. 26 Mar 2019.

Vancouver:

Manrique Torres YJ. Understanding the mechanism of drug delivery from thickened fluids to aid swallowing of medications. [Internet] [Thesis]. University of Queensland; 2015. [cited 2019 Mar 26]. Available from: http://espace.library.uq.edu.au/view/UQ:372163.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Manrique Torres YJ. Understanding the mechanism of drug delivery from thickened fluids to aid swallowing of medications. [Thesis]. University of Queensland; 2015. Available from: http://espace.library.uq.edu.au/view/UQ:372163

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Queensland

19. Radhakrishnan, Chandramouli. Oral medication dose form alteration: patient factors and the effect of adding thickened fluids.

Degree: School of Pharmacy, 2016, University of Queensland

Subjects/Keywords: Swallowing issues; Drug delivery; Dysphagia; Dosage form modification; IVIVC; Thickened fluids; 1115 Pharmacology and Pharmaceutical Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Radhakrishnan, C. (2016). Oral medication dose form alteration: patient factors and the effect of adding thickened fluids. (Thesis). University of Queensland. Retrieved from http://espace.library.uq.edu.au/view/UQ:411689

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Radhakrishnan, Chandramouli. “Oral medication dose form alteration: patient factors and the effect of adding thickened fluids.” 2016. Thesis, University of Queensland. Accessed March 26, 2019. http://espace.library.uq.edu.au/view/UQ:411689.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Radhakrishnan, Chandramouli. “Oral medication dose form alteration: patient factors and the effect of adding thickened fluids.” 2016. Web. 26 Mar 2019.

Vancouver:

Radhakrishnan C. Oral medication dose form alteration: patient factors and the effect of adding thickened fluids. [Internet] [Thesis]. University of Queensland; 2016. [cited 2019 Mar 26]. Available from: http://espace.library.uq.edu.au/view/UQ:411689.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Radhakrishnan C. Oral medication dose form alteration: patient factors and the effect of adding thickened fluids. [Thesis]. University of Queensland; 2016. Available from: http://espace.library.uq.edu.au/view/UQ:411689

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

.